Weight-loss drugs such as semaglutide are effective at tackling the biological drivers of Alzheimer’s disease, a new study ...

A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein ...

Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually ...

A team at Kindai University in Osaka, Japan, fed ordinary L-arginine to fruit flies and mice engineered to develop ...

Alzheimer’s disease prevalence is projected to triple by 2050, indicating a significant public health challenge. Currently, ...

Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and ...

Researchers at Kindai University found that the amino acid L-arginine, costing about $2 a month, reduced amyloid-beta plaques in both fruit fly and mouse Alzheimer’s models. The orally administered ...

Analyze amyloid beta peptides in artificial cerebrospinal fluid using LC–MS/MS with the Xevo TQ Absolute mass spectrometer, ...

Can weight-loss drugs like semaglutide prevent Alzheimer's? New research reveals GLP-1 drugs reduce amyloid and tau proteins in the brain.

Scientists reprogram brain cells to remove Alzheimer’s plaques with a single injection, showing a new approach to long-term ...

For decades, Alzheimer’s disease has been seen as a brain disorder caused by toxic protein buildup, but new research suggests ...